Dr. Andrew Potter is a graduate of Carleton University (Canada) and the University of Otago (New Zealand) and has worked at the Vaccine and Infectious Disease Organization, University of Saskatchewan, for the past 27 years serving as a research scientist, Associate Director (Research) and more recently, Director. His primary research interests are in the areas of the pathogenesis of bacterial respiratory diseases and the development of vaccines for zoonotic diseases. He has previously held an NSERC Senior Industrial Research Chair in the area of vaccine development for food and water safety pathogens. Dr. Potter has mentored more than 40 graduate students and post-doctoral fellows who currently hold positions in industry, academia and government worldwide.
He is also a founding Director and CEO of the Pan-Provincial Vaccine Enterprise (PREVENT), a recently established National Centre of Excellence in Commercialization and Research funded by the National Centres of Excellence Program of the Federal Government, as well as Director of the International Vaccine Centre.
Dr. Potter has served on a number of public and private sector committees and Boards, and has been instrumental in transferring VIDO technology from the laboratory to the private sector.